Flutamide in the treatment of hirsutism
@article{Motta1991FlutamideIT, title={Flutamide in the treatment of hirsutism}, author={Tiziano Motta and G C Maggi and Maria Teresa Perra and E Azzolari and S Casazza and Alberto D'Alberton}, journal={International Journal of Gynecology \& Obstetrics}, year={1991}, volume={36} }
34 Citations
The Use of Antiandrogen of Hirsutism Flutamide in the Treatment
- Medicine, Biology
- 2006
Clinical examinations revealed that after six months of the therapy the dose of flutamide had caused a significant alleviation of hirsutism and this continued during the following months.
The use of antiandrogen flutamide in the treatment of hirsutism.
- Medicine, BiologyEndocrine journal
- 1994
Clinical examinations revealed that after six months of the therapy the dose of flutamide had caused a significant alleviation of hirsutism and this continued during the following months.
Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
- Medicine, BiologyGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
- 1997
Finasteride and flutamide are effective in the treatment of hirsutism in patients with polycystic ovary syndrome and both antiandrogens significantly reduced the Ferriman-Gallwey score and hair diameter.
The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism.
- Medicine, BiologyFertility and sterility
- 1996
Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism.
- MedicineFertility and sterility
- 1999
Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
- Medicine, BiologyFertility and sterility
- 1999
UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
- Medicine, BiologyActa clinica Belgica
- 2013
Combination treatment of IH, including androgen suppression, peripheral androgen blockade and cosmetic methods is most effective.
Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.
- Medicine, BiologyFertility and sterility
- 1995
Very low dose of flutamide in the treatment of hyperandrogenism
- Medicine, BiologyGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
- 2018
Very low dose of flutamide was successful and safe and in the treatment of hyperandrogenism in adolescence and an almost recovery of acne (98% of patients) with better results of those obtained in control group.
References
SHOWING 1-10 OF 11 REFERENCES
Flutamide. Mechanism of action of a new nonsteroidal antiandrogen.
- Biology, MedicineInvestigative urology
- 1976
Flutamide is a new nonsteroidal antiandrogen useful in the treatment of prostatic carcinoma and is capable of inhibiting prostatic nuclear uptake of androgen.
Clinical assessment of body hair growth in women.
- MedicineThe Journal of clinical endocrinology and metabolism
- 1961
A method was developed for the semiquantitative assessment of body hair growth, and suitable for use in the study of clinical problems associated with hirsuties in women, and an “hormonal” score obtained by adding the gradings obtained from 9 of the 11 sites is being employed in clinical studies.
Effect of flutamide on estradiol metabolism.
- Medicine, BiologyThe Journal of clinical endocrinology and metabolism
- 1979
This study demonstrates that flutamide produces multiple functional, reversible, cirrhosis-like disturbances of steroid metabolism, which are universal in the patients studied regardless of whether they had clinical responses toFlutamide, and doubts that the steroid metabolic changes play a role in the therapeutic effect of the drug.
Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy
- MedicineCancer
- 1984
Flutamide appears to be a safe antiandrogen, usually effective in the management of patients with advanced prostatic cancer who have had no prior endocrine therapy.
A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'trifluoromethylisobutyranilide).
- Biology, MedicineEndocrinology
- 1972
A comparative study in castrated rats revealed that Sch 13521 was equipotent to cyproterone acetate (CPA) as an antiandrogen, but unlike CPA, it did not effect parturition time.
Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate
- Biology, MedicineMolecular and Cellular Endocrinology
- 1985
Effect of tlutamide on estradiol metabolism
- J Clin Endocrinol Metab
- 1979
Gambrell KD ( eds ) : The Cause and Management of Hirsutism . Parthenon . Carnforth , UK , 1987 . prior endocrine therapy
Experience with fhnamide in patients with advanced prostatic cancer without
A biological prima CBnier ostetried;ineenlngicsl profile of a nonsteroidal antiandrogen. SCH 13521 L. MuqJagaBi Via Cnnnnend~ 12 (4'~nitro-3'-trifluoromethylisobutyranilide)
- Endocrinology
- 1972